Skip to main content
B

BIO-GENE TECHNOLOGY LTD — Investor Relations & Filings

Ticker · BGT ISIN · AU000000BGT8 ASX Professional, scientific and technical activities
Filings indexed 450 across all filing types
Latest filing 2017-12-18 Regulatory Filings
Country AU Australia
Listing ASX BGT

About BIO-GENE TECHNOLOGY LTD

https://bio-gene.com.au/

Bio-Gene Technology Ltd is a technology company focused on the development and commercialization of novel insecticides derived from naturally occurring chemistry. The company addresses the global challenge of insecticide resistance through its proprietary platform based on beta-triketone chemistry. Its primary product candidates include Flavocide, a nature-identical version of a compound found in specific eucalyptus species, and Qcide, a natural oil extract. These solutions are designed for diverse applications, including crop protection, grain storage, public health, and animal health. By utilizing a unique mode of action, the company provides alternatives to traditional chemical pesticides, aiming to deliver effective pest management with a favorable safety profile for non-target organisms and the environment.

Recent filings

Filing Released Lang Actions
BIO-GENE ANNOUNCES POSITIVE SAFETY RESULTS 1 page 5
Regulatory Filings
2017-12-18 English
BIO-GENE REPORTS POSITIVE INITIAL EFFICACY RESULTS 2 pages 565.4KB
Regulatory Filings
2017-12-10 English
Appendix 3B 13 pages 843.0KB
Regulatory Filings
2017-12-03 English
BIO-GENE APPOINTS MR DOUG RATHBONE AS AN ADVISOR 1
Regulatory Filings
2017-12-03 English
BIO-GENE EXTENDS RESEARCH COLLABORATION WITH QDAF 2 pages 568.6KB
Regulatory Filings
2017-11-30 English
BIO-GENE EXTENDS RESEARCH COLLABORATION WITH CSIRO 2 pages 561.1KB
Regulatory Filings
2017-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.